Precision Medicine
Health is individual and patients can benefit greatly from personalized treatments, tailored for their specific molecular disposition. This rapidly emerging field, known as Precision Medicine, relies on technology development and requires close collaboration between scientists and healthcare professionals. SciLifeLab aims to bring cutting-edge technologies, first-class expertise and data infrastructure to build the foundation of tomorrow’s Precision Medicine.
Contact us – precisionmedicine@scilifelab.se
Call for Clinical Technology Development Projects
The SciLifeLab capabilities for Precision Medicine and Pandemic Laboratory Preparedness now invite clinical researchers and the SciLifeLab infrastructure units and PLP units to submit proposals for collaborative Clinical Technology Development Projects aimed at addressing unmet clinical needs.
Call is open Feb 16 – April 10, 2024
Call for Letter of Interest in Multimodal Precision Medicine
The Precision Medicine Capability now invites clinical researchers (PI) to submit Letters-of-Interest, LoI, for co-developing collaborative projects to test feasibility of generating interoperable multimodal data on clinically relevant samples at SciLifeLab.
Call is open Feb 22 – April 24, 2024
SciLifeLab’s roadmap for precision medicine published
Precision medicine plays an increasingly important role in healthcare, and Sweden has high ambitions to be a leading country within this field. The SciLifeLab capability for precision medicine was established in 2021, and the roadmap for SciLifeLab’s contribution and role within precision medicine has now been published.
Precision Medicine in Almedalen 2023
Hur ska Sverige hänga med i den snabba globala utvecklingen inom precisionsmedicin?
Sverige har en hög ambition att vara världsledande inom life science och precisionsmedicin/hälsa. Hur skapar vi ett globalt konkurrenskraftigt Sverige som säkerställer att nya teknologier, datadriven diagnostik, individanpassad behandling och prevention kommer patienter och samhället till nytta?
During Almedalsveckan 2023, SciLifeLab organized the seminar How should Sweden keep up with the rapid global development in precision medicine? to discuss how to create a globally competitive Sweden that ensures the benefit of new technologies, data-driven diagnostics, personalized treatment, and prevention for patients and society.
Background
Through the Clinical Genomics platform, SciLifeLab has successfully contributed to the implementation of genetic analysis in clinical diagnostics of cancer, inherited disorders and infectious diseases. The Clinical Genomics platform also initiated Genomic Medicine Sweden (GMS) in 2017, to further leverage and translate innovation in genomics into clinical practice. The Clinical Genomics platform and GMS have written a correspondence about their joint efforts to implement precision medicine in Sweden.
Through the Precision Medicine Capability, SciLifeLab aims to enable precision medicine in additional disease areas and technologies building on the existing technologies and expertise available at the infrastructure. A roadmap with more detailed objectives is under preparation. The Precision Medicine Capability works in close collaboration with the DDLS strategic research area for Precision medicine and diagnostics and the SciLifeLab Data Center. We also have regular discussions with other key stakeholders in the precision medicine landscape, including GMS, healthcare regions, and national and international research initiatives.
Services
The Clinical Genomics platform provides a range of clinically validated tests within for example next-generation sequencing and ultrasensitive mutation detection as a service for translational and clinical research, including prospective studies and clinical trials.
Several technologies within proteomics and immunology have been used to support clinical trials and clinical studies.
The National Bioinformatics Infrastructure offers bioinformatics support for different types of projects, including clinical studies.
Information about services and available methods at all technology platforms is available at the pages of each infrastructure unit.
The Drug Discovery and Development platform offers consultation on requirements for precision medicine and how that is implemented in drug discovery research.
The SciLifeLab Precision Medicine Capability arranges the seminar series Clinical Talks, in collaboration with Karolinska Institutet Innovation.
Study explain success story of precision medicine implementation in Sweden
September 29 2022
A bottom-up approach was the key to successfully introduce precision medicine in Swedish healthcare, with academia and healthcare cooperating to build a national infrastructure. This according to a publication written by 42 authors from the Clinical Genomics platform at SciLifeLab and Genomic Medicine Sweden, GMS.
More news
DDLS Data Driven Precision Medicine and Diagnostics expert group appointed
SciLifeLab welcomes Their Majesties from the Netherlands and Sweden
Janne Lehtiö on precision medicine and diagnostics research within the DDLS program
Cancer precision medicine pilot studies produce first annual report
Precision medicine helps young neuroblastoma patient
SciLifeLab hosted Precision Medicine seminar in Almedalen together with Uppsala University
Contact persons
Scientific leads for the SciLifeLab Precision Medicine capability are Päivi Östling, Åsa Johansson and Janne Lehtiö.
Coordinator for the Precision medicine capability is Eva Berglund. Please reach out with any questions, suggestions or research collaboration inquiries.